Breast Cancer (HR HER2-)的临床试验
总计11748个结果
-
Bolt Biotherapeutics, Inc.Hoffmann-La Roche主动，不招人
-
National Cancer Center, Korea主动，不招人
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.未知
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Latin American Cooperative Oncology GroupRoche Pharma AG; Oncoclínicas尚未招聘
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Cancer Trials Ireland招聘中
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
German Breast GroupRoche Pharma AG招聘中
-
iOMEDICO AGSeagen Inc.招聘中
-
Breast Cancer Trials, Australia and New Zealand招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Shanghai Henlius Biotech主动，不招人
-
Daiichi Sankyo完全的
-
Institut Claudius Regaud终止
-
Cancer Institute and Hospital, Chinese Academy...First Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital, China; Beijing Huanxing...未知
-
Hebei Medical University Fourth Hospital未知
-
Merrimack Pharmaceuticals终止乳腺癌 | HER2阳性乳腺癌西班牙, 美国, 意大利, 法国, 加拿大, 比利时, 奥地利, 德国, 捷克共和国
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug Development Institute暂停HER2阳性乳腺癌 | ER 阴性乳腺癌 | PR-阴性乳腺癌 | 淋巴结阴性乳腺癌大韩民国, 法国, 以色列, 比利时, 瑞士, 澳大利亚
-
Cancer Trials Ireland终止转移性乳腺癌 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | 不可切除的乳腺癌爱尔兰, 西班牙
-
Peking University People's Hospital招聘中
-
Peking University People's Hospital招聘中
-
Hoffmann-La Roche主动，不招人
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCare主动，不招人
-
Shanghai Institute Of Biological ProductsFudan University完全的